These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17404291

  • 1. IL-28 elicits antitumor responses against murine fibrosarcoma.
    Numasaki M, Tagawa M, Iwata F, Suzuki T, Nakamura A, Okada M, Iwakura Y, Aiba S, Yamaya M.
    J Immunol; 2007 Apr 15; 178(8):5086-98. PubMed ID: 17404291
    [Abstract] [Full Text] [Related]

  • 2. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 3. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.
    Rosenthal FM, Cronin K, Bannerji R, Golde DW, Gansbacher B.
    Blood; 1994 Mar 01; 83(5):1289-98. PubMed ID: 8118032
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.
    Kaiga T, Sato M, Kaneda H, Iwakura Y, Takayama T, Tahara H.
    J Immunol; 2007 Jun 15; 178(12):7571-80. PubMed ID: 17548592
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M, Falk W, Echtenacher B, Männel DN.
    Eur Cytokine Netw; 1999 Dec 15; 10(4):541-8. PubMed ID: 10586121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma-inducing factor elicits antitumor immunity in association with interferon-gamma production.
    Tan J, Crucian BE, Chang AE, Aruga E, Aruga A, Dovhey SE, Tanigawa K, Yu H.
    J Immunother; 1998 Jan 15; 21(1):48-55. PubMed ID: 9456436
    [Abstract] [Full Text] [Related]

  • 16. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
    Gambotto A, Tüting T, McVey DL, Kovesdi I, Tahara H, Lotze MT, Robbins PD.
    Cancer Gene Ther; 1999 Jan 15; 6(1):45-53. PubMed ID: 10078963
    [Abstract] [Full Text] [Related]

  • 17. Regression of engineered myeloma cells secreting interferon-gamma-inducing factor is mediated by both CD4(+)/CD8(+) T and natural killer cells.
    Xiang J, Chen Z, Huang H, Moyana T.
    Leuk Res; 2001 Oct 15; 25(10):909-15. PubMed ID: 11532525
    [Abstract] [Full Text] [Related]

  • 18. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 Oct 15; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 19. IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model.
    Tang JC, Shen GB, Wang SM, Wan YS, Wei YQ.
    Immunol Lett; 2014 Oct 15; 158(1-2):159-66. PubMed ID: 24406503
    [Abstract] [Full Text] [Related]

  • 20. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H, Kishida T, Hirai H, Satoh E, Ohashi S, Takeuchi M, Kubo T, Kita M, Iwakura Y, Imanishi J, Mazda O.
    Mol Ther; 2002 May 15; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.